2018. Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study. Biomolecules and Biomedicine. 18, 2 (May 2018), 185–190. DOI:https://doi.org/10.17305/bjbms.2017.2279.